School of Life Sciences, The University of Nottingham, Nottingham, UK.
Clin Exp Allergy. 2020 Mar;50(3):291-307. doi: 10.1111/cea.13562. Epub 2020 Feb 4.
Asthma is a chronic, recurrent and incurable allergy-related respiratory disease characterized by inflammation, bronchial hyperresponsiveness and narrowing of the airways. Extracellular vesicles (EVs) are a universal feature of cellular function and can be detected in different bodily fluids. Recent evidence has shown the possibility of using EVs in understanding the pathogenesis of asthma, including their potential as diagnostic and therapeutic tools. Studies have reported that EVs released from key cells involved in asthma can induce priming and activation of other asthma-associated cells. A literature review was conducted on all current research regarding the role and function of EVs in the pathogenesis of asthma via the PRISMA statement method. An electronic search was performed using EMBASE and PubMed through to November 2018. The EMBASE search returned 76 papers, while the PubMed search returned 211 papers. Following duplicate removal, titles and abstracts were screened for eligibility with a total of 34 studies included in the final qualitative analysis. The review found evidence of association between the presence of EVs and physiological changes characteristic of asthma, suggesting that EVs are involved in the pathogenesis, with the weight of evidence presently favouring deleterious effects of EVs in asthma. Numerous studies highlighted differences in exosomal contents between EVs of healthy and asthmatic individuals, which could be employed as potential diagnostic markers. In some circumstances, EVs were also found to be suppressive to disease, but more often promote inflammation and airway remodelling. In conclusion, EVs hold immense potential in understanding the pathophysiology of asthma, and as diagnostic and therapeutic markers. While more research is needed for definitive conclusions and their application in medical practice, the literature presented in this review should encourage further research and discovery within the field of EVs and asthma.
哮喘是一种慢性、复发性和不可治愈的过敏相关呼吸系统疾病,其特征为炎症、支气管高反应性和气道狭窄。细胞外囊泡 (EVs) 是细胞功能的普遍特征,可以在不同的体液中检测到。最近的证据表明,EVs 在理解哮喘发病机制方面具有应用潜力,包括作为诊断和治疗工具的潜力。研究表明,哮喘相关细胞释放的 EVs 可以诱导其他哮喘相关细胞的致敏和激活。通过 PRISMA 声明方法对所有关于 EVs 在哮喘发病机制中的作用和功能的当前研究进行了文献回顾。通过 EMBASE 和 PubMed 进行了电子搜索,截至 2018 年 11 月。EMBASE 搜索返回了 76 篇论文,而 PubMed 搜索返回了 211 篇论文。在删除重复项后,对标题和摘要进行了筛选,以确定是否符合入选标准,共有 34 项研究纳入最终的定性分析。综述发现 EVs 的存在与哮喘特征性的生理变化之间存在关联的证据,表明 EVs 参与了发病机制,目前的证据倾向于 EVs 在哮喘中具有有害作用。许多研究强调了健康个体和哮喘个体之间 EVs 的外泌体内容的差异,这可以作为潜在的诊断标志物。在某些情况下,EVs 也被发现对疾病具有抑制作用,但更多的是促进炎症和气道重塑。总之,EVs 在理解哮喘的病理生理学以及作为诊断和治疗标志物方面具有巨大的潜力。虽然还需要更多的研究来得出明确的结论并将其应用于医学实践,但本综述中提出的文献应该鼓励进一步研究和发现 EVs 和哮喘领域的新发现。